Antibodies

11 Jun 2020 U.S. Food and Drug Administration Approves Opdivo® (nivolumab) for the Treatment of Patients with Advanced Esophageal Squamous Cell Carcinoma (ESCC) After Prior Fluoropyrimidine- and Platinum-based Chemotherapy
10 Jun 2020 Twist Bioscience Partners with Serimmune to Identify SARS-CoV-2 Therapeutic Antibody Candidates
10 Jun 2020 Opthea Reports Positive Phase 2a Trial Results of OPT-302 in Diabetic Macular Edema
10 Jun 2020 Curis Announces FDA Clearance of IND Application for CI-8993, the First-In-Class Monoclonal Anti-VISTA Antibody
10 Jun 2020 Tychan to Begin First Clinical Trials for First Novel Monoclonal Antibody Against COVID-19
10 Jun 2020 Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with Rheumatoid Arthritis
10 Jun 2020 AbbVie and Genmab Announce Broad Oncology Collaboration
10 Jun 2020 Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody
10 Jun 2020 Lyvgen Announces Clinical Trial Collaboration With MSD
10 Jun 2020 Vanderbilt, AstraZeneca sign new COVID-19 antibody agreement
10 Jun 2020 Merck Provides Update on Phase 3 KEYNOTE-361 Trial Evaluating KEYTRUDA® (pembrolizumab) as Monotherapy and in Combination with Chemotherapy in Patients with Advanced or Metastatic Urothelial Carcinoma
09 Jun 2020 Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies
09 Jun 2020 Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer
09 Jun 2020 IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment
08 Jun 2020 Kiniksa Announces 28-Day Clinical Outcomes Data from Mavrilimumab Treatment Protocol in Severe COVID-19 Pneumonia and Active U.S. IND for Phase 2/3 Clinical Trial
08 Jun 2020 CASI Pharmaceuticals Announces Submission Of Clinical Trial Application (IND) To Conduct Phase 1 Study For Anti-38 Monoclonal Antibody Program
08 Jun 2020 Alpine Immune Sciences Provides Clinical Update of its Phase 1 Trial of ALPN-101 in Healthy Volunteers at the European League Against Rheumatism (EULAR) E-Congress 2020
08 Jun 2020 Heat Biologics Announces FDA Clearance of Investigational New Drug (IND) Application for PTX-35
08 Jun 2020 Junshi Biosciences Announces Dosing of First Healthy Volunteer in Phase I Clinical Study of SARS-CoV-2 Neutralizing Antibody JS016 in China
08 Jun 2020 CSL Behring Presents Results for Garadacimab as Preventive Treatment in Hereditary Angioedema
07 Jun 2020 Celldex’s KIT Inhibitor CDX-0159 Demonstrates Profound, Sustained Dose-dependent Reductions in Plasma Tryptase—an Indicator of Mast Cell Burden—and a Favorable Safety Profile
06 Jun 2020 AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19
05 Jun 2020 Biogen Presents Positive Phase 2 Cutaneous Lupus Erythematosus (CLE) Data at European E-Congress of Rheumatology (EULAR) 2020
05 Jun 2020 Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
05 Jun 2020 Alpine Immune Sciences Presents Preclinical Data on Novel Dual BAFF/APRIL Inhibitory Domains for B cell Mediated Autoimmune Diseases at the European Congress of Rheumatology E-Congress 2020

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top